ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,023.95
0.11%
Dow Jones
37,973.81
0.19%
US Dollar vs MXN
16.9106
-0.19%
Brent Oil
83.625
0.10%
Bitcoin
58,384.73
0.25%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tarsus Pharmaceuticals Inc (TARS)

  7. Tarsus Pharmaceuticals Inc (TARS) Noticias

TARS Tarsus Pharmaceuticals Inc

32.04
-0.45 (-1.39%)
Última actualización: 08:59:13
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Tarsus Pharmaceuticals Inc TARS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.45 -1.39% 32.04 08:59:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
32.31 32.02 33.34 32.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202416:00GLOBETarsus to Report First Quarter 2024 Financial Results on..
23/4/202407:30GLOBETarsus Strengthens Financial Position and Refinances..
11/3/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:30GLOBETarsus to Participate at Upcoming Investor Conferences
05/3/202415:09EDGAR2Form 8-K - Current report
05/3/202407:30GLOBETarsus Introduces “Mite Party” Campaign for XDEMVY®..
01/3/202416:26EDGAR2Form 8-K - Current report
01/3/202416:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202423:07GLOBETarsus Announces Pricing of $100.0 Million Public Offering
29/2/202416:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202415:37GLOBETarsus Announces Proposed $100.0 Million Public Offering
29/2/202415:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/2/202415:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202405:00GLOBETarsus Reports Strong Fourth Quarter and Full-Year 2023..
22/2/202407:00GLOBETarsus Announces Positive Topline Results from Carpo, a..
20/2/202416:00GLOBETarsus to Report Fourth Quarter and Full Year 2023 Financial..
31/1/202416:00GLOBETarsus to Participate in Fireside Chat at the Sixth Annual..
30/1/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202416:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/1/202415:30EDGAR2Form 8-K - Current report
08/1/202408:00EDGAR2Form 8-K - Current report
29/12/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202315:23EDGAR2Form 144 - Report of proposed sale of securities
22/12/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:49EDGAR2Form 144 - Report of proposed sale of securities
19/12/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202308:01EDGAR2Form 8-K - Current report
11/12/202307:00GLOBETarsus Announces Positive Topline Results from the Ersa..
01/12/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:35EDGAR2Form 144 - Report of proposed sale of securities
30/11/202315:15EDGAR2Form 144 - Report of proposed sale of securities
21/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
17/11/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:53EDGAR2Form 144 - Report of proposed sale of securities
09/11/202315:18EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202315:05EDGAR2Form 8-K - Current report
09/11/202315:05GLOBETarsus Reports Third Quarter 2023 Financial Results and..
09/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202317:35GLOBETarsus to Report Third Quarter 2023 Financial Results on..
20/10/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202315:26EDGAR2Form 144 - Report of proposed sale of securities
22/9/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202315:30EDGAR2Form 144 - Report of proposed sale of securities
06/9/202307:00GLOBETarsus to Ring Nasdaq Stock Market Closing Bell in..
30/8/202315:30GLOBETarsus to Present at Upcoming Investor Conferences

Su Consulta Reciente

NASDAQ
TARS
Tarsus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados